Alife

Alife Health is a fertility technology company based in San Francisco, founded in 2020.

The company focuses on modernizing and personalizing in-vitro fertilization (IVF) through artificial intelligence (AI) tools. Alife Health aims to enhance clinical decision-making by providing personalized, data-driven insights that help clinicians improve patient outcomes while reducing costs and barriers to access. Alife offers a range of AI-powered solutions, including Embryo PredictTM, which assists in embryo grading and selection, and a machine learning model for optimizing follicle stimulating hormone (FSH) doses. The Alife Mobile App supports patients in the U.S. and Canada by tracking test results, sending medication reminders, and providing educational resources. The company collaborates with leading fertility clinics and networks, including US Fertility and Fertilidad Integral, to drive improvements in reproductive healthcare. Alife Health has been recognized for its innovative approach, earning accolades such as Fast Company’s *Most Innovative Companies of 2024* and the 2024 A’Design Award for Information Technologies Design.